Research is at the core of progress and innovation. Iowa State University’s Nanovaccine Institute understands the importance of pushing boundaries and exploring new frontiers. At Frewitt, we share this commitment to research, using it to drive our lab equipment machines and solve real-world problems.
Frewitt’s FlexMill Lab NW high-performance bead mill is perfect for wet nano milling of pharmaceutical products. With short milling times and lower specific energy, it offers gentle product processing and a tight particle size distribution. Plus, its compact design makes for easy integration and quick set-up in any laboratory.
“Our products are dedicated to research and development, but scalable to production, and are indispensable tools in any university laboratory. We’re thrilled with the Iowa State University’s choice and the trust they’ve placed in us,” said Mr Matthew S. Walczer, Regional Sales Manager at Frewitt USA.
Thanks to the evidence obtained in a laboratory test, our partners, Iowa State’s Nanovaccine Institute and Frewitt will begin a long-term collaboration with full confidence in our tried and proven Nano Mill. This FlexMill Lab with Nano milling head promises to be the ideal partner for the milling of proteins needed for the next generation, ground-breaking vaccine research performed at the university.
“With cutting-edge technology and a commitment to innovation, Frewitt is dedicated to helping us achieve our research goals. We look forward to a fruitful collaboration that will benefit our students and faculty alike,” stated Dr Balaji Narasimhan from Iowa State’s Nanovaccine Institute.
About Frewitt
Frewitt is a leading provider of premium equipment for the milling, crushing, and processing of powders and granulates, serving the pharmaceutical, food, and chemical industries. Known for its Swiss precision and innovation, Frewitt delivers cutting-edge solutions that ensure efficiency, safety, and reliability in processing applications.
About the Nanovaccine Institute at Iowa State University
The Nanovaccine Institute is a consortium of researchers at universities, research institutes, national laboratories, and companies, founded and coordinated by Iowa State University. Our purpose is to use nano-based technologies to tackle emergent diseases that have a devastating impact on human and animal health. Our focus areas include respiratory infections, antimicrobial resistance, neural disorders, cancer, animal health, and aging and obesity.